期刊文献+

胃袖状切除术与Roux—en—Y胃旁路术治疗2型糖尿病疗效的Meta分析 被引量:5

Efficacies of sleeve gastrectomy and Roux-en-Y gastric bypass for the treatment of type 2 diabetes melli- tus a Meta-analysis
原文传递
导出
摘要 目的系统评价胃袖状切除术与Roux—en—Y胃旁路术治疗2型糖尿病的疗效。方法以减重手术、胃切除术、胃绕道术、胃旁路手术、胃转流术、胃袖状切除术、糖尿病、bariatricsurgery、gastricbypass、sleevegastrectomy、diabetes、T2DM等为关键词检索Cochranelibrary、PubMed、中国期刊全文数据库、中国生物医学文献数据库、中文科技期刊全文数据库和万方数据库。检索时间为各数据库建库至2012年12月。最终纳入胃袖状切除术对比Roux—en—Y胃旁路术治疗2型糖尿病的相关文献,再由2名研究者分别独立提取数据并进行文献质量评价,用RevMan5.1.2软件进行Meta分析。计数资料采用相对危险度(riskratio,RR)或比值比(oddsratio,OR)分析统计,计量资料采用均数差(meandifference,MD)或标准差(standardmeandifference,SMD)分析统计。采用Jr2对异质性进行定量分析。结果共纳入符合标准的文献5篇,其中胃袖状切除术组164例,Roux—en—Y胃旁路术组184例。Meta分析结果显示:与胃袖状切除术比较,Roux—en—Y胃旁路术能更显著地提高患者糖尿病的缓解率(OR=0.48,95%C/:0.26~0.91,P〈0.05),提高随访期间停止服药的比例(OR=0.37,95%C/:0.16~0.84,P〈0.05),更有效降低糖化血红蛋白水平(MD=0.28,95%C/:0.14—0.43,P〈0.05)和体质量(MD=-0.44,95%CI:-0.76~-0.13,P〈0.05)。胃袖状切除术与Roux—ell—Y胃旁路术患者术后并发症发生率比较,差异无统计学意义(OR=1.81,95%C/:0.20~16.73,P〉0.05)。结论Roux—en—Y胃旁路术较胃袖状切除术在治疗2型糖尿病的疗效方面具有一定的优势。 Objective To review the efficacies of sleeve gastrectomy and Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus. Methods The Cochrane library, PubMed, China Journal Full Text Data- base, Chinese Scientific Journal Full Text Database, Chinese Biomedical Literature Database and Wanfang Data- base were searched with key words including "bariatric surgery", "gastric bypass", "sleeve gastrectomy", "diabe- tes", "T2DM" and et al. Literatures published between the time of database establishment and December 2012 were searched. Literatures focused on the comparison of the efficacies of sleeve gastrectomy and Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus were retrieved. Data extraction and quality evaluation of the literatures were done by 2 researchers independently. Meta analysis was performed by RevMan 5.1.2 software. The count data were presented by risk ratio (RR) or odds ratio (OR) , and the measurement data were presented by mean difference (MD) or standard mean difference (SMD). The heterogeneity of the literatures was analyzed by I2. Results Five literatures were retrieved, including 164 patients in the sleeve gastrectomy group and 184 patients in the Roux-en-Y gastric bypass group. The results of Meta analysis showed that Roux-en-Y gastric bypass could significantly increase the remission rate of type 2 diabetes (OR =0. 48, 95% confidence interval: O. 26-0. 91, P 〈 0.05 ), increase the percentage of patients without drugs during follow up ( OR = 0. 37, 95 % confidence interval : 0. 16-0. 84, P 〈 0.05) , decrease the levels of HbAle and body weight (MD = 0. 28, -0. 44, 95% confidenceinterval : 0. 14-0.43, - 0. 76-- 0. 13, P 〈 0.05 ) when compared with sleeve gastrectomy. There was no significant difference in the incidence of complications between the 2 groups (OR = 1.81, 95% confidence interval: O. 20- 16. 73, P 〉 0.05 ). Conclusion Roux-en-Y gastric bypass is superior to sleeve gastrectomy for patients with type 2 diabetes.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2013年第12期921-926,共6页 Chinese Journal of Digestive Surgery
基金 兰州大学国家级大学生创新创业训练计划项目(201210730175)
关键词 糖尿病 2型 胃袖状切除术 Roux—en—Y胃旁路术 META分析 Diabetes mellitus, type 2 Sleeve gastrostomy Roux-en-Y gastric bypass Meta analysis
  • 相关文献

参考文献19

  • 1Zimmel P, Alberti KG, Sha J. Global md societll impli'ati.ns of Ihe diabetes elfidemic. Nature,2001,414(6865 ) :782-787.
  • 2Yang W, 1,u J, Weng J, el al. Prealence of diabetes among men and women in China. N Engl J Med ,2010,362( 12 ) :1090-1101.
  • 3Mingrone G, Panunzi S, De Gaelano A, et al. Barialric surgen vs. conventional medical therapy for type 2 diabetes. N Engl JMed,2012,366(17):1577-1585.
  • 4Buehwald H, Estok R, Fahrbach K, et al. Weight and type 2 dia- betes after bariatric surgery: systematic review and recta-analysis. Am J Med ,2009,122 ( 3 ) :248-256.
  • 5Raj PP, Kunmravel R, Chandramaliteeswaran C, et al. Laparo- scopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India. Surg Endosc,2012,26 (3) :688-692.
  • 6杨景哥,王存川,胡友主,李进义,潘运龙,沈莹莹,黎泳欣,黄璟,俞春亮,刘贤明.腹腔镜Roux-en-Y胃旁路手术治疗肥胖症和2型糖尿病[J].中华胃肠外科杂志,2010,13(8):594-597. 被引量:15
  • 7徐键,王勇,刘源,刘金钢.胃转流术治疗2型糖尿病的研究进展[J].中华内分泌外科杂志,2010,4(2):132-134. 被引量:8
  • 8Sjtistrm L, Lindroos AK, Peltonsen M, et al. Lifestyle, diabe- tes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med,2004,351 (26):2683-2693.
  • 9Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care,2009,32( 11 ) :2133-2135.
  • 10Scbauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery ver- sus intensive medical therapy in obese patients with diabetes. N Engl J Med,2012,366(17) :1567-1576.

二级参考文献53

  • 1蔡发成,向晓光,陈懿菁.2型糖尿病患者皮质醇与糖化血红蛋白检测的临床意义[J].实用医技杂志,2005,12(06B):1575-1576. 被引量:4
  • 2张士虎,苗毅.胃旁路术对非肥胖型糖尿病大鼠的降糖作用[J].南京医科大学学报(自然科学版),2006,26(3):176-179. 被引量:13
  • 3郑成竹,胡兵.腹腔镜手术治疗肥胖病的新概念[J].中华消化外科杂志,2007,6(3):164-165. 被引量:23
  • 4Francesco R, Michel G. Potential of surgery for curing type 2 diabetes mellitus[ J]. Ann Surg, 2002,236(6) :554 - 559.
  • 5Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult -onset diabetes mellitus [ J ]. Ann Surg, 1995,222 ( 3 ) : 339 - 352.
  • 6Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mecganisms of weight loss and diabetes resolution[ J]. J Clin Endocri Metab,2004,89(6) :2608 -2615.
  • 7Wick remesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study [ J ]. Obes Surg,2005,15 ( 6 ) :474 - 481.
  • 8Wang Q, Brubaker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice [ J ]. Diabetologia, 2002,45(8) :1263 - 1273.
  • 9Simon A. Gastrointestinal surgery and gut hormones [ J ]. Current Opinon in Endocrinology & Diabetes,2005,12( 1 ) :89 -98.
  • 10Kral JG. Selection of patients for anti-obesity surgery [ J ]. Int J Obes,2001,25( Supp 1 ) :107 - 112.

共引文献39

同被引文献50

  • 1武阳丰,马冠生,胡永华,李艳平,李贤,崔朝辉,陈春明,孔灵芝.中国居民的超重和肥胖流行现状[J].中华预防医学杂志,2005,39(5):316-320. 被引量:567
  • 2郑成竹,李心翔,胡兵.中国肥胖病现状及减肥手术的新概念——腹腔镜手术治疗肥胖病的手术指征及疗效评判新标准[J].中国实用外科杂志,2007,27(2):134-135. 被引量:38
  • 3Nauck M, Stockmann F, Ebert R, et al. Reduced incre- tin effect in type 2 (non-insulin-dependent) diabetes [ J]. Diabetologia, 1986,29( 1 ) :46-52.
  • 4Martin J H, Deacon C F, Gorrell M D, et al. Incretin- based therapies-review of the physiology, pharmacology and emerging clinical experience [J]. Intern Med J, 2011,41 (4) :299-307.
  • 5Nathan D M, Schreiber E, Fogel H, et al. Insulinotropic action of glucagonlike peptide-I-(7-37 ) in diabetic and nondiabetic subjects [ J ]. Diabetes Care, 1992,15 ( 2 ) : 270 -276.
  • 6Kreymann B, Williams G, Ghatei M A, et al. Glucagon- like peptide-1 7-36: a physiological incretin in man[ J]. Lancet, 1987,2 (8571) :1300-1304.
  • 7Nauck M A, Niedereichholz U, Ettler R, et al. Gluca- gon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans [ J ]. Am J Physiol, 1997,273(5 Pt 1) :E981-E988.
  • 8Willms B, Werner J, Hoist J J, et al. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 ( GLP- 1) -(7-36) amide in type 2 (noninsulin-dependent) dia- betic patients [J]. J Clin Endocrinol Metab, 1996, 81 ( 1 ) :327-332.
  • 9Flint A, Raben A, Astrup A, et al. Glucagon-like pep- tide 1 promotes satiety and suppresses energy intake in humans[ J]. J Clin Invest, 1998,101 (3) :515-520.
  • 10Gutzwiller J P, Drewe J, Goke B, et al. Glucagon-like peptide-1 promotes satiety and reduces food intake in pa- tients with diabetes mellitus type 2 [ J]. Am J Physiol, 1999,276(5 Pt 2) :R1541-R1554,.

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部